A Phase II Single-Arm Study of Therapeutic Iobenguane (131I) For Relapsed, High-Risk Neuroblastoma Subjects (OPTIMUM Trial) PROTOCOL MIBG 2014-01
|Effective start/end date
|2/1/19 → 2/28/25
- JUBILANT DRAXLMAGE INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.